Literature DB >> 28811328

Transglutaminase 2 Is a Direct Target Gene of YAP/TAZ-Letter.

Chen-Ying Liu1,2, Ajaybabu V Pobbati2, Zhenyu Huang3, Long Cui3, Wanjin Hong4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28811328     DOI： 10.1158/0008-5472.CAN-16-3535

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  Transglutaminase 2 Is a Direct Target Gene of YAP-TAZ-Response.

Authors:  Matthew L Fisher; Gautam Adhikary; Candace Kerr; Daniel Grun; Richard L Eckert
Journal:  Cancer Res       Date:  2017-08-15       Impact factor: 12.701

2.  Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling.

Authors:  Chinmayee D Bhedi; Sabina Nasirova; Deniz Toksoz; Rod R Warburton; Kevin J Morine; Navin K Kapur; Jonas B Galper; Ioana R Preston; Nicholas S Hill; Barry L Fanburg; Krishna C Penumatsa
Journal:  FASEB J       Date:  2019-11-28       Impact factor: 5.191

3.  Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.

Authors:  Zhenzhen Yan; Haihong Shi; Rongrong Zhu; Lele Li; Bai Qin; Lihua Kang; Hui Chen; Huaijin Guan
Journal:  Mol Vis       Date:  2018-01-31       Impact factor: 2.367

4.  Periodic Heat Stress Licenses EMSC Differentiation into Osteoblasts via YAP Signaling Pathway Activation.

Authors:  Wentao Shi; Zhe Wang; Lu Bian; Yiqing Wu; Mei HuiYa; Yanjun Zhou; Zhijian Zhang; Qing Wang; Peng Zhao; Xiaojie Lu
Journal:  Stem Cells Int       Date:  2022-03-18       Impact factor: 5.443

Review 5.  A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy.

Authors:  Ajaybabu V Pobbati; Wanjin Hong
Journal:  Theranostics       Date:  2020-02-18       Impact factor: 11.556
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.